Study summary · 2025 · Evidence review

Telehealth costs during the COVID-19 pandemic

Patient costs may fall with telehealth, but effects on total spending remain uncertain and application-specific.

Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence

Original publication

The Effect of Telehealth on Cost of Health Care During the COVID-19 Pandemic: A Systematic Review

Lauren Lavin; Heath Gibbs; J Priyanka Vakkalanka; Sara Ternes; Heather S Healy; Kimberly A S Merchant; Marcia M Ward; Nicholas M Mohr

University of Iowa: College of Public Health, Carver College of Medicine and Hardin Library for the Health Sciences, United States

Telemedicine and e-Health · Online: · Issue: March 2025

Final journal abstract; online November 18, 2024; March 2025 issue, volume 31(3), pages 310–319. A separate November 2024 research brief updates the search and is not treated as this article. · Summary limited to the accessible abstract.

What was studied

Design
Evidence review
Population
Patients using telehealth during the COVID-19 public health emergency
Sample
12 included studies from 8,557 screened records
Intervention
Telehealth applications of varying modalities
Comparator
Study-specific cost comparisons
Follow-up
No common duration reported in the accessible abstract
Review search cutoff
2023-05-26
Setting
Multiple countries; detailed distribution not available in the abstract

Methods

Four-database systematic review, supplemented by government and rural-health website searches in June 2023. Costs were separated into patient, payer and health-sector perspectives.

Findings

The abstract reports increased telehealth spending alongside lower patient costs and limited changes in monthly total spending. Results differed by application; no pooled monetary estimate or confidence interval is supplied.

Limitations

Abstract-only appraisal: detailed costing assumptions and individual estimates were unavailable. Included studies had heterogeneous modalities and cost definitions and, on average, moderate bias risk.

What this means for care delivery

Patient savings do not establish payer or health-system savings. This source cannot supply a transferable return-on-investment estimate.